Glucocorticoid regulation of dopamine clearance, cocaine seeking, and reward

糖皮质激素对多巴胺清除、可卡因寻求和奖励的调节

基本信息

  • 批准号:
    8720462
  • 负责人:
  • 金额:
    $ 34.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-15 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): An insidious aspect of addiction is that afflicted individuals are at risk of relapse even after extended periods of abstinence. Stressful life events are important contributors to relapse in recovering cocaine addicts, but the mechanisms by which they influence motivational systems are poorly understood. Studies suggest that stress may "set the stage" for relapse by increasing the sensitivity of brain reward circuits to drug-associated stimuli. This proposal seeks to elucidate the mechanisms by which stress, through increases in glucocorticoid hormones, influences relapse vulnerability. We have previously shown that treatment of rodents with stress levels of glucocorticoids does not lead to reinstatement of drug-seeking behavior, but potentiates reinstatement in response to a dose of cocaine that, by itself, is not sufficient to trigger relapse. In parallel to its behavioral effect, corticosterone pretreatment also potentiates the effects of low-dose cocaine on extracellular dopamine concentration in the nucleus accumbens, suggesting that glucocorticoids may potentiate drug seeking by enhancing dopaminergic neurotransmission in this critical reward-processing brain region. We are examining the role of organic cation transporter 3, a high-capacity dopamine transporter that is acutely and directly inhibited by glucocorticoids, in mediating the effects of glucocorticoids on dopaminergic neurotransmission, cocaine relapse, and motivated behavior in rodents. Because of a lack of pharmacologically specific inhibitors for OCT3, we are using two different genetic approaches to test the hypothesis that corticosterone potentiates cocaine-induced dopaminergic neurotransmission and drug-seeking behavior by inhibiting OCT3-mediated clearance of dopamine in the nucleus accumbens. In the first aim, we will determine the impact of corticosterone-induced inhibition of dopamine clearance in the nucleus accumbens on dopamine signaling and drug relapse by using in vivo microdialysis and fast-scan cyclic voltammetry to measure dopamine concentration and clearance in cocaine-seeking animals. In the second aim, we will determine the role of OCT3 in the behavioral and neurochemical effects of corticosterone by examining corticosterone effects on drug-seeking behavior and nucleus accumbens dopamine signaling in animals genetically modified to lack OCT3 expression either globally or specifically in the nucleus accumbens. In the third aim, we will test the hypothesis that corticosterone-induced decreases in dopamine clearance modulate reward sensitivity and natural reward processing. These findings will thoroughly characterize a novel mechanism by which stress hormones can rapidly regulate dopamine signaling and contribute to the impact of stress on drug intake and motivated behavior in general.
描述(由申请人提供):成瘾的一个阴险的方面是,即使在长期戒断之后,受折磨的人也有复发的风险。生活压力事件 是导致可卡因成瘾者复吸的重要因素,但人们对它们影响动机系统的机制知之甚少。研究表明,压力可能会增加大脑奖赏回路对药物相关刺激的敏感性,从而为旧病复发“埋下伏笔”。该提案旨在阐明压力通过糖皮质激素增加而影响复发易感性的机制。我们之前已经表明,用糖皮质激素应激水平治疗啮齿类动物不会导致寻药行为的恢复,但会增强对可卡因剂量的恢复,而可卡因本身不足以引发复发。与其行为效应并行,皮质酮预处理还增强了低剂量可卡因对伏隔核细胞外多巴胺浓度的影响,这表明糖皮质激素可能通过增强这一关键奖励处理大脑区域的多巴胺能神经传递来增强药物寻求。我们正在研究有机阳离子转运蛋白 3(一种高容量多巴胺转运蛋白,可被糖皮质激素急性直接抑制)在介导糖皮质激素对啮齿类动物多巴胺能神经传递、可卡因复吸和动机行为的影响中的作用。由于缺乏 OCT3 的药理学特异性抑制剂,我们正在使用两种不同的遗传学方法来检验以下假设:皮质酮通过抑制 OCT3 介导的伏隔核中多巴胺的清除来增强可卡因诱导的多巴胺能神经传递和药物寻求行为。第一个目标是,通过使用体内微透析和快速扫描循环伏安法测量可卡因动物体内的多巴胺浓度和清除率,确定皮质酮诱导的伏隔核多巴胺清除率抑制对多巴胺信号传导和药物复发的影响。在第二个目标中,我们将通过检查皮质酮对药物寻求行为和伏隔核多巴胺信号传导的影响,确定 OCT3 在皮质酮的行为和神经化学效应中的作用,这些动物经过基因改造,在整体或伏隔核中特异性缺乏 OCT3 表达。在第三个目标中,我们将检验以下假设:皮质酮引起的多巴胺清除率降低会调节奖励敏感性和自然奖励处理。这些发现将彻底描述一种新机制,通过该机制,应激激素可以快速调节多巴胺信号传导,并有助于压力对药物摄入和总体动机行为的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID A BAKER其他文献

DAVID A BAKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID A BAKER', 18)}}的其他基金

PACAP-Dependent Coordination of Glutamate Signaling between Neurons and Astrocytes
神经元和星形胶质细胞之间谷氨酸信号传导的 PACAP 依赖性协调
  • 批准号:
    10053148
  • 财政年份:
    2020
  • 资助金额:
    $ 34.6万
  • 项目类别:
PACAP-Dependent Coordination of Glutamate Signaling between Neurons and Astrocytes
神经元和星形胶质细胞之间谷氨酸信号传导的 PACAP 依赖性协调
  • 批准号:
    10402872
  • 财政年份:
    2020
  • 资助金额:
    $ 34.6万
  • 项目类别:
PACAP-Dependent Coordination of Glutamate Signaling between Neurons and Astrocytes
神经元和星形胶质细胞之间谷氨酸信号传导的 PACAP 依赖性协调
  • 批准号:
    10612429
  • 财政年份:
    2020
  • 资助金额:
    $ 34.6万
  • 项目类别:
Glucocorticoid regulation of dopamine clearance, cocaine seeking, and reward
糖皮质激素对多巴胺清除、可卡因寻求和奖励的调节
  • 批准号:
    9061043
  • 财政年份:
    2014
  • 资助金额:
    $ 34.6万
  • 项目类别:
Glucocorticoid regulation of dopamine clearance, cocaine seeking, and reward
糖皮质激素对多巴胺清除、可卡因寻求和奖励的调节
  • 批准号:
    8920526
  • 财政年份:
    2014
  • 资助金额:
    $ 34.6万
  • 项目类别:
Role of System xc- in Addiction: Developing & Phenotyping a Slc7a11 knockout rat
系统 xc- 在成瘾中的作用:发展
  • 批准号:
    8608513
  • 财政年份:
    2013
  • 资助金额:
    $ 34.6万
  • 项目类别:
Role of System xc- in Addiction: Developing & Phenotyping a Slc7a11 knockout rat
系统 xc- 在成瘾中的作用:发展
  • 批准号:
    8463353
  • 财政年份:
    2013
  • 资助金额:
    $ 34.6万
  • 项目类别:
Targeting System Xc- for the Treatment of Addiction
用于治疗成瘾的靶向系统 Xc-
  • 批准号:
    7737627
  • 财政年份:
    2009
  • 资助金额:
    $ 34.6万
  • 项目类别:
Targeting System Xc- for the Treatment of Addiction
用于治疗成瘾的靶向系统 Xc-
  • 批准号:
    7894918
  • 财政年份:
    2009
  • 资助金额:
    $ 34.6万
  • 项目类别:
Targeting System Xc- for the Treatment of Schizophrenia
靶向系统 Xc- 用于治疗精神分裂症
  • 批准号:
    8397352
  • 财政年份:
    2008
  • 资助金额:
    $ 34.6万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 34.6万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了